Australia markets close in 5 hours 23 minutes
  • ALL ORDS

    7,358.90
    -82.60 (-1.11%)
     
  • ASX 200

    7,055.10
    -84.40 (-1.18%)
     
  • AUD/USD

    0.7153
    -0.0034 (-0.48%)
     
  • OIL

    84.02
    +0.71 (+0.85%)
     
  • GOLD

    1,842.60
    +0.90 (+0.05%)
     
  • BTC-AUD

    51,331.40
    +352.67 (+0.69%)
     
  • CMC Crypto 200

    839.82
    +29.22 (+3.60%)
     
  • AUD/EUR

    0.6314
    -0.0019 (-0.29%)
     
  • AUD/NZD

    1.0670
    -0.0032 (-0.30%)
     
  • NZX 50

    12,190.89
    -0.17 (-0.00%)
     
  • NASDAQ

    14,509.58
    +71.18 (+0.49%)
     
  • FTSE

    7,297.15
    -196.98 (-2.63%)
     
  • Dow Jones

    34,364.50
    +99.13 (+0.29%)
     
  • DAX

    15,011.13
    -592.75 (-3.80%)
     
  • Hang Seng

    24,656.46
    -309.09 (-1.24%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     

Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript

·42-min read
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • CORT

Statements during this call, other than statements of historical facts, are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties which may cause actual results to differ materially from those such statements express or imply. The availability of competing treatments, including generic versions of Korlym, our ability to obtain acceptable prices or adequate insurance coverage and reimbursement for Korlym, risks related to the development of our product candidates, including their clinical attributes, regulatory approvals, mandates and oversights and other requirements, and the scope and protective power of our intellectual property.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting